Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Hypoxia Inducible Factor as a Cancer Drug Target

Volume:3   Issue:6
Pp: 391-405
Sarah J. Welsh and Garth Powis
DOI: 10.2174/1568009033481732

Nitric Oxide-Releasing Non Steroidal Anti-Inflammatory Drugs: A New Generation of Anti-Tumoral Molecules

Volume:3   Issue:6
Pp: 407-426
Christian Lavagna, Piero Del Soldato, Jean-Luc Burgaud and Patrick Rampal
DOI: 10.2174/1568009033481750

Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies

Volume:3   Issue:6
Pp: 427-432
E. Fonsatti, L. Sigalotti, P. Arslan, M. Altomonte and M. Maio
DOI: 10.2174/1568009033481741

Thomsen-Friedenreich Disaccharide Immunogenicity

Volume:3   Issue:6
Pp: 433-443
Fernando J. Irazoqui and Gustavo A. Nores
DOI: 10.2174/1568009033481714